A Study of Evaluating Dual Inhibitor of PAK4 and NAMPT ATG-019 in Advanced Solid Tumors or Non-Hodgkin's Lymphoma
Clinical trial NCT04281420 · TERMINATED
Trial details
- NCT number
- NCT04281420
- Sponsor
- Antengene Therapeutics Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-13
- Primary completion
- 2023-10-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.